[1] CYBULSKA B, KŁOSIEWICZ-LATOSZEK L. Landmark studies in coronary heart disease epidemiology. The Framingham Heart Study after 70 years and the Seven Countries Study after 60 years[J]. Kardiol Pol, 2019, 77(2):173-180. [2] NDREPEPA G, COLLERAN R, KASTRATI A. Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease[J].Clin Chim Acta, 2018, 76(7):130-138. [3] KOCHERGIN N A, KOCHERGINA A M, GANYUKOV V I, et al. Predictors of coronary plaque vulnerability in patients with stable coronaryartery disease[J]. Kardiologiia, 2020, 60(10):20-26. [4] 吴湘军, 郑海燕, 朱亚兰. 血清同型半胱氨酸,尿酸,超敏C反应蛋白水平与腔隙性脑梗死患者颈动脉粥样硬化程度的关系探讨[J]. 实用医院临床杂志, 2020, 17(2):220-223. [5] 中华医学会老年医学分会,高龄老年冠心病诊治中国专家共识写作组. 高龄老年冠心病诊治中国专家共识[J]. 中华老年医学杂志, 2016, 35(7):683-691. [6] FERENCIK M, MAYRHOFER T, BITTNER D O, et al. Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the promise randomized clinical trial[J]. JAMA Cardiol, 2018, 3(2):144-152. [7] GALAL H, RASHID T, ALGHONAIMY W, et al. Detection of positively remodeled coronary artery lesions by multislice CT and its impact on cardiovascular future events[J]. Egypt Heart J, 2019, 71(1):26-26. [8] 郝家明. 血清TBIL、Lp(a)和CysC检测在冠心病诊断中的临床价值[J]. 中国热带医学, 2015, 15(8):977-980. [9] 董茜, 韩晓涛, 陈永福, 等. 不同类型冠心病患者血清Hcy、TBIL、hs-CRP、尿酸的表达及临床意义[J]. 现代生物医学进展, 2020, 20(9):79-82. [10] 张云红, 赵义娟, 沙敏, 等. 老年原发性高血压患者颈动脉粥样硬化斑块与血清标志物之间的相关性分析[J]. 中华老年心脑血管病杂志, 2018, 20(4):374-377. [11] BADIMON L, PEÑA E, ARDERIU G, et al. C-reactive protein in atherothrombosis and angiogenesis[J]. Front Immunol, 2018, 2(9):430-430. [12] 孔勇, 王莹, 刘海超, 等. 血清同型半胱氨酸在脑梗死急性期及颈动脉粥样硬化斑块形成中的作用[J]. 中国临床保健杂志, 2018, 21(6):45-48. [13] 魏群,周萍.老年高血压患者颈动脉粥样硬化与血清同型半胱氨酸、脂蛋白(a)、尿酸的关系[J]. 实用老年医学, 2016, 30(6):490-492. [14] 张静, 陈宏勃, 邢玥, 等. 应用血管内视镜观察不稳定性动脉斑块的形成及其与冠心病危险因素的关系[J]. 中国介入心脏病学杂志, 2006, 14(2):127-127. |